サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：人工網膜の世界市場：2023-2030年
市場調査レポート
商品コード
1380452

人工網膜の世界市場：2023-2030年

Global Artificial Retina Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 105 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
人工網膜の世界市場：2023-2030年
出版日: 2023年10月01日
発行: Orion Market Research
ページ情報: 英文 105 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工網膜市場は予測期間（2023-2030年）にCAGR 8.1％で成長すると予測されています。人工網膜市場の成長は、加齢黄斑変性症や網膜色素変性症などの網膜疾患の有病率の増加と、高度な眼科治療に対する需要の高まりに起因しています。さらに、人工網膜装置の技術的進歩、ヘルスケア支出の増加、これらの装置の利用可能性に関する患者の意識の高まりが、今後数年間の市場成長を促進すると予想されます。世界保健機関（WHO）によると、世界全体で少なくとも22億人が近視または遠視の障害を持っています。このうち少なくとも10億人は、視力障害を予防できたか、まだ対処できていないです。世界レベルでの視力障害と失明の主な原因は、屈折異常と白内障です。

セグメント別展望

研究機関が人工網膜の世界市場で大きなシェアを占めると予想される

エンドユーザーの中でも、研究機関のサブセグメントが世界の人工網膜市場でかなりのシェアを占めると予想されています。このセグメントの成長は、より良い高度な治療に対する需要の高まりに起因しており、そのため企業や研究機関は、より良い改良されたデバイスの研究や追跡に一層注力しています。例えば、2020年6月には、香港科学技術大学（HKUST）の科学者が率いる国際チームが、既存のバイオニックアイよりも優れた能力を持ち、場合によっては人間の目の能力を超える世界初の3D人工眼球を開発したばかりであり、ヒューマノイドロボットに視覚をもたらし、視覚障害を持つ患者に新たな希望をもたらしています。

地域別展望

世界の人工網膜市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。なかでも欧州は、経済開拓と英国、ドイツなどの政府支援の増加により、世界市場で突出したシェアを占めると予想されています。例えば、2022年1月、バイオニック・アイ・インプラントにより、盲目の英国人女性が視覚信号を検出できるようになっています。ダゲナムに住むこの女性は、地理的萎縮症を患っています。この症状は、乾性加齢黄斑変性症（AMD）の最も一般的な形態であり、世界中で数百万人が罹患し、視力を失う可能性があります。

北米地域は人工網膜の世界市場において著しいCAGRで成長すると予想される

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長は、強力なヘルスケアインフラと医療産業における研究開発への高い支出に起因しています。例えば、2020年1月、ピッツバーグ大学医療センター（UPMC）は、永続的な失明につながる疾患である進行性加齢黄斑変性（AMD）患者の部分的な視力回復を目的とした臨床試験の一環として、米国初の患者に新しいワイヤレス網膜デバイスを移植しました。これとは別に、この地域では、主要な既存企業による製品上市が着実に増加しており、同地域の医療セクターをさらに発展させ、ひいては市場成長を後押ししています。米国国立医学図書館によると、アルファAMS網膜下インプラントは6人中5人の参加者の視力を改善し、最大24ヵ月間その機能を維持しています。移植手術は依然として難しいが、光干渉断層計（OCT）顕微鏡ガイダンスなどの新たな開発により、手術手技に改良が加えられました。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Aetna Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Bionic Vision Technologies
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Pixium Vision
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 人工網膜の世界市場：製品タイプ別
    • 網膜上インプラント
    • 網膜下インプラント
    • Epineuralインプラント
  • 人工網膜の世界市場：エンドユーザー別
    • 病院
    • 診療所
    • 研究機関

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Altris, Inc.
  • Axorus
  • Bionic Vision Technologies
  • Intelligent Implants, Ltd.
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Medtronic
  • Nano Retina
  • Nidek Co. Ltd.
  • Optobionics
  • Retina Implant AG
  • Vivani Medical Inc.
図表

LIST OF TABLES

  • 1. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 2. GLOBAL EPIRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL SUBRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL EPINEURAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 6. GLOBAL ARTIFICIAL RETINA IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ARTIFICIAL RETINA IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ARTIFICIAL RETINA IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 13. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 15. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 16. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 18. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL EPIRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL SUBRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL EPINEURAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY END USER, 2022 VS 2030 (%)
  • 6. GLOBAL ARTIFICIAL RETINA IN HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ARTIFICIAL RETINA IN CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ARTIFICIAL RETINA IN RESEARCH INSTITUTES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. US ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. FRANCE ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. GERMANY ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. ITALY ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. SPAIN ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SOUTH KOREA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027759

Title: Global Artificial Retina Market Size, Share & Trends Analysis Report by Type (Epiretinal Implants, Subretinal Implants, and Epineural implants), and by End User (Hospital, Clinics, and Research institutes)Forecast Period (2023-2030).

The global artificial retina market is anticipated to grow at a CAGR of 8.1% during the Forecast Period (2023-2030). The growth of the artificial retina market can be attributed to the increasing prevalence of retinal diseases such as age-related macular degeneration and retinitis pigmentosa, along with the growing demand for advanced ophthalmic treatments. Additionally, technological advancements in artificial retina devices, increasing healthcare expenditure, and rising awareness among patients about the availability of these devices are expected to drive market growth in the coming years. According to World Health Organization (WHO), globally, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of these, vision impairment could have been prevented or is yet to be addressed. The leading causes of vision impairment and blindness at a global level are refractive errors and cataracts.

Segmental Outlook

The global artificial retina market is segmented on the type and end user. Based on the type, the market is sub-segmented into epiretinal Implants, subretinal Implants and epineural implants. And Based on the end user, the market is sub-segmented into hospital, clinics, and research institutes. Among the type, the Epiretinal Implants sub-segment is anticipated to hold a considerable share of the market, Owing to it better and safety features. It can be implanted and removed through a smaller incision than subretinal implants. This reduces the risk of complications and makes it easier to replace the implant if necessary.

The Research Institutes Sub-Segment is Anticipated to Hold a Considerable Share of the Global Artificial Retina Market

Among the end user, the research institutes sub-segment is expected to hold a considerable share of the global artificial retina market. The segmental growth is attributed to the increasing demand for better and advanced treatment, hence the companies and research institutes are focusing more on research and trails of better and improved devices. For instance, in June 2020, an international team led by scientists at the Hong Kong University of Science and Technology (HKUST) has recently developed the world's first 3D artificial eye with capabilities better than existing bionic eyes and in some cases, even exceed those of the human eyes, bringing vision to humanoid robots and new hope to patients with visual impairment.

Regional Outlook

The global artificial retina market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the economic development coupled with the increasing government support in countries such as UK, Germany, and others. For instance, in January 2022, Bionic eye implant enables blind UK woman to detect visual signals. The woman from Dagenham suffers from geographic atrophy. The condition is the most common form of dry age-related macular degeneration (AMD), which affects millions of people worldwide and can cause loss of sight.

The North America Region is Expected to Grow at a Significant CAGR in the Global Artificial Retina Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to strong healthcare infrastructure and high expenditure in R&D in medical industry. For instance, in January 2020, University of Pittsburgh Medical Center (UPMC) implanted the first patient in the US with a new wireless retinal device as part of a clinical trial aimed at restoring partial sight to patients with advanced age-related macular degeneration (AMD), a disease that leads to permanent blindness. Apart from this, the regions is witnessing a steady increase in product launches by key established companies, further advancing medical sector in the region, in turn propelling the market growth. According to National Library of Medicine, the Alpha AMS subretinal implant improved visual performance in 5 of 6 participants and has exhibited ongoing function for up to 24 months. Although implantation surgery remains challenging, new developments such as optical coherence tomography (OCT) microscope guidance added refinements to the surgical technique.

Market Players Outlook

The major companies serving the global artificial retina market include: Altris, Inc., Axorus, Bionic Vision Technologies, Intelligent Implants, Ltd., Labtician Ophthalmics, Inc., LambdaVision, Inc., Medtronic, Nano Retina, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2023, RetinAI and Boehringer Ingelheim have joined forces to advance the identification and treatment of geographic atrophy using artificial intelligence (AI). This partnership holds the potential to revolutionize treatments by tailoring them more precisely to each patient's specific condition. Ultimately, this collaboration aims to transform the lives of individuals affected by retinal diseases.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global artificial retina market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Aetna Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bionic Vision Technologies
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Pixium Vision
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Artificial retina Market by Product Type
    • 4.1.1. Epiretinal Implants
    • 4.1.2. Subretinal Implants
    • 4.1.3. Epineural Implants
  • 4.2. Global Artificial retina Market by End User
    • 4.2.1. Hospital
    • 4.2.2. Clinics
    • 4.2.3. Research Institutes

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Altris, Inc.
  • 6.2. Axorus
  • 6.3. Bionic Vision Technologies
  • 6.4. Intelligent Implants, Ltd.
  • 6.5. Labtician Ophthalmics, Inc.
  • 6.6. LambdaVision, Inc.
  • 6.7. Medtronic
  • 6.8. Nano Retina
  • 6.9. Nidek Co. Ltd.
  • 6.10. Optobionics
  • 6.11. Retina Implant AG
  • 6.12. Vivani Medical Inc.